J Clin Microbiol 1985, 22:996–1006.PubMed 44. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nuc Acids Res 1997, 25:3389–3402.CrossRef Authors’ contributions MK was responsible for the conception and design of the study, and was involved in construction of shuttle-cloning C188-9 mouse vectors, pKP1 plasmid cloning and sequencing

as well as in writing the draft and final version of the manuscript. BJ performed the experiments to analyse cell surface proteins and the effects of ions, pH and proteinase K on aggregation ability of the analysed strains, and was involved in sequencing and in silico analysis of pKP1 plasmid. IS participated in construction of plasmid pKP1 derivatives.

JB was involved in construction of pAZ1, pAZIL and pAZILcos vectors and interpretation of data. JL participated in homologous and heterologous expression of aggregation phenotype. KV carried out plasmid profile analysis and standardization of transformation protocols. LT critically revised the manuscript and gave final approval of the version to be published. All authors read and approved the final manuscript.”
“Background The human colon constitutes a protective and nutrient-rich habitat to trillions of bacteria living in symbiosis with the host [1]. This complex consortium constantly competes with exogenous microbes for attachment www.selleckchem.com/products/Belinostat.html sites in the brush border of intestinal epithelial cells, thus preventing pathogens from entering specific ecological niches and gut tissues [2]. Pathogens may however overcome this line of defense, leading to different manifestations of disease. Infectious gastroenteritis

caused by non-typhoidal strains of Salmonella enterica spp. enterica is an important cause of morbidity and mortality worldwide [3]. Due to the increasing incidence of antibiotic resistant and more virulent serovars [4], the use of probiotics with specific anti-Salmonella activities is a prevailing interest. Mechanisms by which probiotics inhibit pathogens include competition for nutritional substrates and adhesion pheromone sites on intestinal epithelial cells, secretion of antimicrobial substances as well as toxin inactivation and host immunity stimulation [5]. However, in vivo mechanistic studies of probiotics and gut microbiota are hindered by ethical considerations, compliance issues and high costs. A variety of in vitro gut Mizoribine mw models have been applied to separately investigate microbe-microbe and simple microbe-host interactions [6–8]. Owing to the complexity of the intestinal environment, suitable models accounting for all intestinal parameters including both the gut microbiota and their substrates and metabolic products as well as the presence of epithelial intestinal cells, represent an indispensable platform for preclinical probiosis assessment.